|
2026 Other Outputs Symptom management for chemotherapy-induced peripheral neuropathy, and Ogle, Theodora (2026). Symptom management for chemotherapy-induced peripheral neuropathy. doi: 10.5204/thesis.eprints.248955 |
|
2024 Journal Article Influences shaping clinicians’ monoclonal antibody and immune checkpoint inhibitor preparation and administration management practices: a systematic reviewBallard, Angela, Thamm, Carla, Ogle, Theodora and Phillips, Jane L. (2024). Influences shaping clinicians’ monoclonal antibody and immune checkpoint inhibitor preparation and administration management practices: a systematic review. Seminars in Oncology Nursing, 40 (2) 151583, 1-9. doi: 10.1016/j.soncn.2024.151583 |
|
2021 Journal Article Patient preferences for using technology in communication about symptoms post hospital dischargeAlexander, Kim E., Ogle, Theodora, Hoberg, Hana, Linley, Libbie and Bradford, Natalie (2021). Patient preferences for using technology in communication about symptoms post hospital discharge. BMC Health Services Research, 21 (1) 141, 1-11. doi: 10.1186/s12913-021-06119-7 |
|
2021 Journal Article Occurrence and perceived effectiveness of activities used to decrease chemotherapy-induced peripheral neuropathy symptoms in the feetOgle, Theodora, Alexander, Kimberly, Yates, Patsy, Paul, Steven M., Kober, Kord M., Conley, Yvette P., Schumacher, Mark, Levine, Jon D. and Miaskowski, Christine (2021). Occurrence and perceived effectiveness of activities used to decrease chemotherapy-induced peripheral neuropathy symptoms in the feet. European Journal of Oncology Nursing, 54 102025, 1-8. doi: 10.1016/j.ejon.2021.102025 |
|
2020 Journal Article Systematic review of the effectiveness of self-initiated interventions to decrease pain and sensory disturbances associated with peripheral neuropathyOgle, Theodora, Alexander, Kimberly, Miaskowski, Christine and Yates, Patsy (2020). Systematic review of the effectiveness of self-initiated interventions to decrease pain and sensory disturbances associated with peripheral neuropathy. Journal of Cancer Survivorship, 14 (4), 444-463. doi: 10.1007/s11764-020-00861-3 |
